# Intranasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV)

> **NCT01475305** · PHASE1 · TERMINATED · sponsor: **MedImmune LLC** · enrollment: 7 (actual)

## Conditions studied

- RSV Infection

## Interventions

- **DRUG:** Placebo
- **DRUG:** MEDI-557

## Key facts

- **NCT ID:** NCT01475305
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-10-20
- **Primary completion:** 2011-12-03
- **Final completion:** 2012-12-13
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** The study was terminated as it was determined to not be feasible to complete enrollment and the study within the required timeline and budget.
- **Last updated:** 2017-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01475305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01475305, "Intranasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01475305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*